Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Saitama Medical University Non-Profit Organaizaion "LINE" |
---|---|
Information provided by: | Saitama Medical University |
ClinicalTrials.gov Identifier: | NCT00288717 |
To investigate the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid-metabolism in the hypertensive patients with the accumulation of visceral fat by the newly developed Tele-medicine system
Condition | Intervention |
---|---|
Hypertension |
Drug: Candesartan Drug: Telmisartan |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | A Randomized, Comparative Study of the Effects of Candesartan and Telmisartan on the Home Blood Pressure, Glucose and Lipid Metabolism in the Hypertensive Patients With the Accumulation of Visceral Fat by the Central Registration System |
Estimated Enrollment: | 300 |
Study Start Date: | February 2006 |
Estimated Study Completion Date: | September 2007 |
A randomized, comparative study of the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid metabolism in the hypertensive patients with the accumulation of visceral fat by the central registration system
Ages Eligible for Study: | 20 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Hidetomo Nakamoto, MD | +81-0492-76-1258 | nakamo_h@saitama-med.ac.jp |
Japan, Saitama | |
Saitama Medical School Department of Renal Medicine | Recruiting |
Saitama City, Saitama, Japan, 350-0495 | |
Contact: Hidetomo Nakamoto, MD +81-492-76-1258 nakamo_h@saitama-med.ac.jp | |
Principal Investigator: Hidetomo Nakamoto, MD |
Principal Investigator: | Hidetomo Nakamoto, MD | Saitama Medical School Department of Renal Medicine |
Study ID Numbers: | FUJIYAMA-Study, UMIN-CTR-C000000324 |
Study First Received: | February 7, 2006 |
Last Updated: | January 9, 2007 |
ClinicalTrials.gov Identifier: | NCT00288717 History of Changes |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Angiotensin II Type 1 Receptor Blockers Candesartan cilexetil Obesity Candesartan Vascular Diseases Angiotensin-Converting Enzyme Inhibitors |
Cardiovascular Agents Telmisartan Angiotensin II Antihypertensive Agents Protease Inhibitors Hypertension |
Molecular Mechanisms of Pharmacological Action Vascular Diseases Enzyme Inhibitors Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions Protease Inhibitors Candesartan cilexetil |
Angiotensin II Type 1 Receptor Blockers Therapeutic Uses Candesartan Angiotensin-Converting Enzyme Inhibitors Cardiovascular Diseases Telmisartan Hypertension |